Stephen C. Glover - 12 Jan 2026 Form 4 Insider Report for PDS Biotechnology Corp (PDSB)

Reporting relationship: Director
Issuer ticker: PDSB
Reported as of: 12 Jan 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 03 Mar 2026, 18:47:21 UTC
Prior SEC filing: 15 Jul 2025
Next SEC filing: 03 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Spencer Brown, as Attorney-in-Fact

Key filing fact

Stephen C. Glover filed Form 4 for PDS Biotechnology Corp (PDSB) on 03 Mar 2026.

Key facts

This page summarizes Stephen C. Glover's Form 4 filing for PDS Biotechnology Corp (PDSB).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 03 Mar 2026, 18:47.

Change

Previous filing in this sequence was filed on 15 Jul 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001304406 Primary reporting owner

Glover Stephen C.

Relationship: Director
Address: C/O PDS BIOTECHNOLOGY CORPORATION, 303A COLLEGE ROAD EAST, PRINCETON
Signature: /s/ Spencer Brown, as Attorney-in-Fact
Signature date: 03 Mar 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PDSB transaction Derivative

Employee Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +54,876
Change %
Price: $0.000000
Shares after: 54,876
Date: 12 Jan 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 54,876
Exercise price: $0.9800
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The Stock Option will vest in full and become fully exercisable on the first anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer as a director through such date.